Bonita David P 4
4 · Prelude Therapeutics Inc · Filed Jun 18, 2024
Insider Transaction Report
Form 4
Bonita David P
Director10% Owner
Transactions
- Award
Director Stock Option (Right to Buy)
2024-06-14+23,500→ 23,500 totalExercise: $3.90Exp: 2034-06-13→ Common Stock (23,500 underlying)
Footnotes (2)
- [F1]The option award will fully vest upon the earlier of (a) the Issuer's next annual stockholder meeting, or (b) the one-year anniversary of the grant date, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F2]Pursuant to an agreement with OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC, the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VI, LP.